Cargando…

Exenatide with Metformin Ameliorated Visceral Adiposity and Insulin Resistance

BACKGROUND: To study the effectiveness of exenatide with metformin and sequential treatment with exenatide and glargine added to metformin and their influence on insulin sensitivity and adipose distribution. METHODS: 20 newly diagnosed obese type 2 diabetic patients were enrolled, and 2-month washou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Xuan, Lu, Wen, Lu, Zijun, Shao, Xinyu, Hu, Chunhong, Shi, Bimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818885/ https://www.ncbi.nlm.nih.gov/pubmed/29541641 http://dx.doi.org/10.1155/2018/4019248

Ejemplares similares

AMPK Activation by Metformin Suppresses Abnormal Extracellular Matrix Remodeling in Adipose Tissue and Ameliorates Insulin Resistance in Obesity
por: Luo, Ting, et al.
Publicado: (2016)

Visceral Adipose Tissue is Associated with Insulin Resistance in Hemodialyzed Patients
por: Giers, Kinga, et al.
Publicado: (2015)

Exenatide improves hepatocyte insulin resistance induced by different regional adipose tissue
por: Bai, Chuanmin, et al.
Publicado: (2022)

Effects of canagliflozin and metformin on insulin resistance and visceral adipose tissue in people with newly-diagnosed type 2 diabetes
por: Hao, Zirui, et al.
Publicado: (2022)

Effects of metformin and Exenatide on insulin resistance and AMPKα-SIRT1 molecular pathway in PCOS rats
por: Tao, Xin, et al.
Publicado: (2019)

Metformin Rescues the MG63 Osteoblasts against the Effect of High Glucose on Proliferation
por: Shao, Xinyu, et al.
Publicado: (2014)

Low Plasma Adiponectin Concentrations Predict Increases in Visceral Adiposity and Insulin Resistance
por: Han, Seung Jin, et al.
Publicado: (2017)

Cut-Off Values of Visceral Adiposity to Predict NAFLD in Brazilian Obese Adolescents
por: Grotti Clemente, Ana Paula, et al.
Publicado: (2013)

Study of Postprandial Lipaemia in Type 2 Diabetes Mellitus: Exenatide versus Liraglutide
por: Voukali, Maria, et al.
Publicado: (2014)

Could Metformin Manage Gestational Diabetes Mellitus instead of Insulin?
por: Saleh, Hend S., et al.
Publicado: (2016)

Visceral adiposity, insulin resistance and cancer risk
por: Donohoe, Claire L, et al.
Publicado: (2011)

Effects of Exercise, Metformin, Pioglitazone and Exenatide Treatment on Inflammation Induced Insulin Resistance and Ubiquitin Proteasome System in Diabetes and Obesity
por: Akarsu, Ersin, et al.
Publicado: (2021)

Effects of Exenatide and Humalog Mix25 on Fat Distribution, Insulin Sensitivity, and β-Cell Function in Normal BMI Patients with Type 2 Diabetes and Visceral Adiposity
por: Wang, Xinlei, et al.
Publicado: (2020)

Effects of Visceral Fat Accumulation Awareness on a Web-Based Weight-Loss Program: Japanese Study of Visceral Adiposity and Lifestyle Information—Utilization and Evaluation (J-VALUE)
por: Sakane, Naoki, et al.
Publicado: (2013)

Effects of Metformin on the Regulation of Free Fatty Acids in Insulin Resistance: A Double-Blind, Placebo-Controlled Study
por: Castro Cabezas, Manuel, et al.
Publicado: (2012)

Accuracy of Longitudinal Assessment of Visceral Adipose Tissue by Dual-Energy X-Ray Absorptiometry in Children with Obesity
por: Dias, Katrin A., et al.
Publicado: (2019)

Exenatide once weekly combined with metformin reduced glycemic variability in type 2 diabetes by using flash glucose monitoring system
por: Li, Yang, et al.
Publicado: (2020)

Association between visceral adiposity index and heart failure: A cross‐sectional study
por: Zhang, Xinyu, et al.
Publicado: (2023)

Effects of Exenatide Plus Rosiglitazone on β-Cell Function and Insulin Sensitivity in Subjects With Type 2 Diabetes on Metformin
por: DeFronzo, Ralph A., et al.
Publicado: (2010)

Limited Effects of Endurance or Interval Training on Visceral Adipose Tissue and Systemic Inflammation in Sedentary Middle-Aged Men
por: Cooper, Joshua H. F., et al.
Publicado: (2016)

Adiposity and insulin resistance correlate with telomere length in middle-aged Arabs: the influence of circulating adiponectin
por: Al-Attas, Omar S, et al.
Publicado: (2010)

SUBCUTANEOUS ADIPOSE TISSUE INSULIN RESISTANCE IS ASSOCIATED WITH VISCERAL ADIPOSITY IN POSTMENOPAUSAL WOMEN
por: Casey, Beret A., et al.
Publicado: (2014)

Lifestyle Intervention Involving Calorie Restriction with or without Aerobic Exercise Training Improves Liver Fat in Adults with Visceral Adiposity
por: Yoshimura, Eiichi, et al.
Publicado: (2014)

Higher Ratio of Abdominal Subcutaneous to Visceral Adipose Tissue Related with Preservation of Islet β-Cell Function in Healthy Individuals
por: Liu, Juan, et al.
Publicado: (2017)

Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study
por: Abdul-Ghani, Muhammad, et al.
Publicado: (2017)

Enzamin ameliorates adipose tissue inflammation with impaired adipocytokine expression and insulin resistance in db/db mice
por: Tamura, Yukinori, et al.
Publicado: (2013)

Randomized Trial of Continuous Subcutaneous Delivery of Exenatide by ITCA 650 Versus Twice-Daily Exenatide Injections in Metformin-Treated Type 2 Diabetes
por: Henry, Robert R., et al.
Publicado: (2013)

Association of visceral adiposity and insulin resistance with colorectal adenoma and colorectal cancer
por: Jung, In Sub, et al.
Publicado: (2019)

Molecular tracking of insulin resistance and inflammation development on visceral adipose tissue
por: Bensussen, Antonio, et al.
Publicado: (2023)

Short-term combined treatment with exenatide and metformin for overweight/obese women with polycystic ovary syndrome
por: Ma, Rui-Lin, et al.
Publicado: (2021)

Timing of Exercise Affects Glycemic Control in Type 2 Diabetes Patients Treated with Metformin
por: Huang, Tao, et al.
Publicado: (2018)

Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes
por: Sarkar, Gayatri, et al.
Publicado: (2014)

Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin: A proof-of-concept study
por: Arnolds, Sabine, et al.
Publicado: (2010)

Insulin and Metformin Regulate Circulating and Adipose Tissue Chemerin
por: Tan, Bee K., et al.
Publicado: (2009)

Epistaxis in Visceral Leishmaniasis with Hematological Correlation
por: Sigdel, B., et al.
Publicado: (2012)

Endovascular Embolisation of Visceral Artery Pseudoaneurysms
por: Khattak, Yasir Jamil, et al.
Publicado: (2014)

Comparison of exenatide alone or combined with metformin versus metformin in the treatment of polycystic ovaries: a systematic review and meta-analysis
por: Hu, Yan, et al.
Publicado: (2023)

Comparison of exenatide with biphasic insulin aspart 30 on glucose variability in type 2 diabetes: study protocol for a randomized controlled trial
por: Xu, Shaoyong, et al.
Publicado: (2016)

Drug interaction between hydroxychloroquine and metformin
Publicado: (2020)

Negative association of acetate with visceral adipose tissue and insulin levels
por: Layden, Brian T, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_o7is3fn19glji6hd5gr0ggqcar